The National Institutes of Health is permanently closing one of two pharmacies that had issues with sterility processes, according to an article on The Wall Street Journal website.
The facilities received critical reports of their sterility processes a year ago from the Food and Drug Administration.
Both facilities are located in the NIH Clinical Center, which largely treats patients who are entered in clinical studies.
An FDA inspection in May 2015 found what the agency termed “significant violations of current good manufacturing practice” at the PDS, such as failing to thoroughly investigate discrepancies in drug batches.
Site Selection Mistakes: What Not To Do
High-Performance EFCO Systems Shape MUSC's New Black River Medical Center
Heritage Valley Health System to Officially Affiliate with Alleghany Health Network
The Impact of Acoustics on Patient Privacy
Texas Behavioral Health Center in Dallas Opens with Ribon-Cutting Ceremony